Komodo Health

Market position

Positions itself as operator of the most comprehensive U.S. healthcare data foundation and as ahead of legacy data aggregators; an investor in the Series E described the company as increasingly a leading partner to top pharma and emerging biotech. Komodo was named 2020 Company of the Year for Real-World Evidence in Healthcare by Frost & Sullivan (sources 0, 4).

The company argues its combination of a proprietary, comprehensive linked U.S. patient data foundation with healthcare-specific, auditable and reproducible AI — configured to a customer's own questions, logic and workflows rather than a fixed model — cannot be replicated by competitors (sources 0, 1).

Technology

The Healthcare Map links de-identified claims and other healthcare data from hundreds of sources into longitudinal patient records — described as 1 trillion+ linked records across 330M+ patients, refreshed daily — using artificial intelligence and advanced data analytics. Marmot adds an AI/agent layer supporting natural-language, multi-step analytical workflows with reproducible and auditable outputs, plus pre-built analytic modules, low/no-code tools and the ability to connect proprietary and third-party data (sources 0, 4, 7).

Go-to-market

Direct enterprise sales and demo-led motion ("Request a Demo" workflows with therapeutic-area-specific live walkthroughs) aimed at life sciences and healthcare organizations, supported by a platform/ecosystem approach in which customers and partners build their own applications on Komodo's data and AI layer. Leadership includes a Chief Marketing Officer responsible for go-to-market strategy and a Chief Business Officer leading the Mavens unit (sources 0, 2, 7).

Life sciences and pharmaceutical companies, biotechs, healthcare payers and health plans, providers and health systems, patient advocacy groups, digital health companies, and academic institutions (sources 0, 4, 5, 7).

Geography

U.S.-centric data coverage, with offices in New York City; San Francisco; Los Altos, California (Silicon Valley); Chicago; and Chennai, India (source 3). A prior listing gives a San Francisco address at 680 Folsom St, Suite 500 (source 6). The Mavens unit is described as delivering global enterprise software and services (source 2).

History

Founded in 2014, Komodo built the Healthcare Map as the core of its enterprise technology platform. It raised a $50M Series C in January 2020, and in early 2021 announced both a Series D led by ICONIQ Growth and the acquisition of Mavens, a cloud-computing provider for life sciences; it also acquired market access software company Breakaway Partners in 2021. In March 2021 it closed a $220M Series E led by Tiger Global at a reported $3.3 billion valuation. In December 2022 it disclosed a $200M structured equity investment led by Coatue with Dragoneer, alongside a restructuring that cut 78 employees (9% of staff), and put previously discussed IPO plans on hold. More recently the company shifted to an AI-first positioning around its Marmot platform, named Miles Ennis president, appointed Paul Thomas CFO, and expanded a strategic partnership with Alnylam (sources 2, 4, 5, 7).

Risks & controversies

In December 2022 Komodo announced a restructuring that eliminated 78 full-time roles, or 9% of its workforce, citing macroeconomic pressure, and shelved near-term IPO plans amid market conditions; the December 2022 financing was structured equity rather than a conventional priced round (source 7). Reported employee counts vary widely across sources (source 5 lists 10,000+, while the 2022 layoff figures imply roughly 870 employees at that time), indicating uncertain headcount data.